Aspirin vs. Warfarin after bioprosthetic valve surgery
Treatments studied
Part of Heart & circulation clinical trials.
This trial compares aspirin to warfarin in the first six months after receiving a bioprosthetic (tissue) heart valve. It aims to find which treatment better prevents blood clots without causing excessive bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- You had a successful surgery to replace a heart valve with a bioprosthetic (tissue) valve in the aortic or mitral position
- You are within the first day after surgery
- You do not have a mechanical (artificial) heart valve
- You have not had a hemorrhagic (bleeding) stroke in the last 3 months
- You do not need blood thinners for other reasons like atrial fibrillation or deep vein thrombosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two blood-thinning medicines, apixaban and warfarin, for people who had heart valve repair or a tissue (biological) valve replacement and also have atrial fibrillation. It aims to see which medicine is safer and works better in the first three months after surgery.
This trial compares two blood-thinning treatments after aortic valve replacement with a tissue valve. It tests if a convenient pill (apixaban) is as safe and effective as aspirin alone, to prevent blood clots and other complications. Participation could help improve recovery and reduce the risk of strokes and bleeding.
This trial compares two medicines to prevent blood clots after heart valve surgery. If you've had a tissue valve replaced or repaired, this study will see if a newer blood thinner (rivaroxaban) is safer and works better than the standard treatment.
This study compares a blood thinner pill (a factor Xa inhibitor) with warfarin (vitamin K antagonist) in people who have had a mechanical aortic valve replacement. It looks at which option works better and is safer over the long term.
This study checks whether a blood-thinning medicine can treat problems with a bioprosthetic (man-made tissue) aortic valve. It focuses on valve “clots” that can happen after either a catheter-based or surgery-based valve replacement.
This trial tests whether taking aspirin alone is as safe and effective as taking aspirin with warfarin after a TAVR procedure for severe aortic regurgitation. It is for people who do not need long-term blood thinners for other conditions.
Hear when a new Valve Replacement Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.